Back to Research Hub
Novo Nordisk A/S
NVO
$42.19+1.17 (+2.85%)
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.
StreetsValue research for Novo Nordisk A/S (NVO)
Members get the full report for Novo Nordisk A/S: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.